Genetics Visit Uptake Among Individuals Receiving Clinically Actionable Genomic Screening Results.

ABSTRACT:

Importance

Screening unselected populations for clinically actionable genetic disease risk can improve ascertainment and facilitate risk management. Genetics visits may encourage at-risk individuals to perform recommended management, but little has been reported on genetics visit completion or factors associated with completion in genomic screening programs.

Objective

To identify factors associated with postdisclosure genetics visits in a genomic screening cohort.

Design, setting, and participants

This was a cohort study of biobank data in a health care system in central Pennsylvania. Participants' exome sequence data were reviewed for pathogenic or likely pathogenic (P/LP) results in all genes on the American College of Medical Genetics and Genomics Secondary Finding

SUBMITTER: Schwartz MLB 

PROVIDER: S-EPMC10943406 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature